// App-Quantinova.ai

: Response and outcomes of maintenance avelumab after platinum-based chemotherapy (PBC) in patients (pts) with advanced urothelial carcinoma (aUC): "Real world" experience.

Researchers

Presenter

  • Dimitra Rafailia Bakaloudi

Principal Investigators

  • Dimitrios Makrakis

  • Neeraj Agarwal

  • Nishita Tripathi

  • Aristotelis Bamias

  • Roubini Zakopoulou

  • Jason Brown

  • James Korolewicz

  • Claudia A.M. Fulgenzi

  • Tanya Jindal

  • Jure Murgic

  • Ana Fröbe

  • Jeffrey Johnson

  • Alexandra Drakaki

  • Alejo Rodríguez-Vida

  • Macarena Rey-Cárdenas

  • Lucia Andrea Alonso Buznego

  • Ali Raza Khaki

  • Petros Grivas

Medical Centers

  • Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, School of Medicine, Athens, Greece

  • Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA

  • University of Washington, WA

  • KBC “Sestre milosrdnice”, Zagreb, ON, Croatia

  • Athens University, Athens, Greece

  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • Marques de Valdecilla University Hospital, Santander, Spain

  • Department of Oncology University Hospital Center Sisters of Mercy University of Zagreb Medical School, Zagreb, Croatia

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Department of Haematology, Imperial College London, Hammersmith Hospital, London, United Kingdom

  • Imperial College, London, United Kingdom

  • Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY

  • Hospital del Mar Medical Research Institute, Barcelona, Spain

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Division of Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH

Locations

  • Croatia

  • Spain

  • Greece

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Advanced Urothelial Carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • Avelumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved